HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Galanin and galanin receptor type 1 suppress proliferation in squamous carcinoma cells: activation of the extracellular signal regulated kinase pathway and induction of cyclin-dependent kinase inhibitors.

Abstract
Galanin receptor 1 (GALR1) maps to a common region of 18q loss in head and neck squamous cell carcinomas and is frequently inactivated by methylation. To investigate effects of GALR1 and its signaling pathways, we stably expressed hemaglutinin-tagged GALR1 in a human oral carcinoma cell line (UM-SCC-1-GALR1) that expresses no endogenous GALR1. In transfected cells, galanin induced activation of the extracellular-regulated protein kinase-1/2 (ERK1/2) and suppressed proliferation. Galanin stimulation mediated decreased expression of cyclin D1 and increased expression of the cyclin-dependent kinase inhibitors (CKI), p27(Kip1) and p57(Kip2). Pretreatment with the ERK1/2-specific inhibitor U0126 prevented these galanin-induced effects. Phosphatidylinositol 3-kinase (PI3K) pathway activation did not differ in UM-SCC-1-GALR1 and UM-SCC-1-mock cells after galanin treatment. Pertussis toxin and LY294002 inhibition demonstrated that galanin and GALR1 induce ERK1/2 activation via Galphai, not the PI3K pathway-linked to the Gbetagamma subunit. Galanin and GALR1 also inhibit colony formation and tumor growth in vivo. Our results implicate GALR1, a Gi protein-coupled receptor, as a tumor suppressor gene that inhibits cell proliferation via ERK1/2 activation.
AuthorsT Kanazawa, T Iwashita, P Kommareddi, T Nair, K Misawa, Y Misawa, Y Ueda, T Tono, T E Carey
JournalOncogene (Oncogene) Vol. 26 Issue 39 Pg. 5762-71 (Aug 23 2007) ISSN: 0950-9232 [Print] England
PMID17384686 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Cyclin-Dependent Kinase Inhibitor Proteins
  • Fas Ligand Protein
  • Receptor, Galanin, Type 1
  • Cyclin D1
  • Galanin
  • Phosphatidylinositol 3-Kinases
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
Topics
  • Carcinoma, Squamous Cell (enzymology, pathology)
  • Cell Proliferation (drug effects)
  • Colony-Forming Units Assay
  • Cyclin D1 (metabolism)
  • Cyclin-Dependent Kinase Inhibitor Proteins (metabolism)
  • Enzyme Activation (drug effects)
  • Fas Ligand Protein (metabolism)
  • Galanin (pharmacology)
  • Humans
  • Immunoblotting
  • Mitogen-Activated Protein Kinase 1 (metabolism)
  • Mitogen-Activated Protein Kinase 3 (metabolism)
  • Mouth Neoplasms (enzymology, pathology)
  • Oligonucleotide Array Sequence Analysis
  • Phosphatidylinositol 3-Kinases (metabolism)
  • Receptor, Galanin, Type 1 (physiology)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Signal Transduction (drug effects)
  • Transfection
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: